Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 626-632

  Eugster, Hans Pietro ^a   Frei, Karl ^a   Bachmann, Rosilla ^c   Bluethmann, Horst ^b   Lassmann, Hans ^c   Fontana, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c University Hospital Zurich ^*

Author keywords

Autoimmunity; Inflammation; Knockout; Neuroimmunology; Tumor necrosis factor

Indexed keywords

MYELIN PROTEIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; INFLAMMATION; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0033032129     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A     Document Type: Article

References (31)

1. Steinman, L., Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996. 85: 299-302.
2. Selmaj, K., Raine, C. S., Cannella, B. and Brosnan, C. F., Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 1991. 87: 949-954.
3. Bernard, C. C., Leydon, J. and Mackay, I. R., T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 1976. 6: 655-660.
4. Olsson, T., Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 1995. 144: 245-268.
5. Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J. and Clark, R. B., An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 1990. 172: 1193-1200.
6. Selmaj, K., Raine, C. S. and Cross, A. H., Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 1991. 30: 694-700.
7. Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T., Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor. I. J. Neuroimmunol. 1995. 56: 135-141.
8. Korner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S. and Sedgwick, J. D., Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol. 1997. 27: 1973-1981.
9. Klinkert, W., Kojima, K., Lesslauer, W., Rinner, Lassmann, H. and Wekerle, H., TNF-alpha receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: An overview. J. Neuroimmunol. 1997. 72: 163-168.
10. Frei, K., Eugster, H. P., Bopst, M., Constantinescu, C. S., Lavi, E. and Fontana, A., Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 1997. 185: 2177-2182.
11. Suen, W. E., Bergman, C. M., Hjelmstrom, P. and Ruddle, N. H., A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 1997. 186: 1233-1240.
12. Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L. and Bernard, C. C., TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 1998. 4: 78-83.
13. Riminton, D. S., Koerner, H., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D., Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxindeficient, but not tumor necrosis factor-deficient mice. J. Exp. Med. 1998. 187: 1-12.
14. Dopp, J. M., Mackenzie, G. A., Otero, G. C. and Merrill, J. E., Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 1997. 75: 104-112.
15. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., Russel, J. H., Karr, R. and Chaplin, D. D., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994. 264: 703-707.
16. Eugster, H. P., Muller, M., Karrer, U., Car, B. D., Schnyder, B., Eng, V. M., Woerly, G., Le Hir, M., di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H. and Ryffel, B., Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int. Immunol. 1996. 8: 23-36.
17. Neumann, B., Luz, A., Pfeffer, K. and Holzmann, B., Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 1996. 184: 259-264.
18. Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H. and Kollias, G., Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor [published erratum appears in Proc. Natl. Acad. Sci. USA 1997. 94: 9510]. Proc. Natl. Acad. Sci. USA 1997. 94: 6319-6323.
19. Le Hir, M., Bluethmann, H., Kosco-Vilbois, M. H., Muller, M., di Padova, F., Moore, M., Ryffel, B. and Eugster, H. P., Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 1996. 183: 2367-2372.
20. Lassmann, H., Brunner, C., Bradl, M. and Linington, C., Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. (Berl.) 1988. 75: 566-576.
21. Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H. and Iglesias, A., B lymphocytes producing demyelinating autoantibodies. Development and function in gene-targeted transgenic mice. J. Exp. Med. 1998. 188: 169-180.
22. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. and Fontana, A., IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 1998. 28: 2178-2187.
23. Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J. M., Gardinier, M. V., Dommair, K. and Linington, C., The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 1995. 63: 17-27.
24. Sacca, R., Cuff, C. A., Lesslauer, W. and Ruddle, N. H., Differential activities of secreted lymphotoxin-alpha(3) and membrane lymphotoxin-alpha(1)beta(2) in lymphotoxin-induced inflammation: Critical role of TNF receptor 1 signaling. J. Immunol. 1998. 160: 485-491.
25. Mori, L., lselin, S., De, L. G. and Lesslauer, W., Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-lgG1 -treated and TNFR1-deficient mice. J. Immunol. 1996. 157: 3178-3182.
26. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G. and Kollias, G., Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 1995. 92: 11294-11298.
27. Selmaj, K. W. and Raine, C. S., Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988. 23: 339-346.
28. Malipiero, U., Frei, K., Spanaus, K. S., Agresti, C., Lassmann, H., Hahne, M., Tschopp, J., Eugster, H. P. and Fontana, A., Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/ relapsing in perforin knockout mice, but monophasic in Fas-and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 1997. 27: 3151-3160.
29. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M. and Bluethmann, H., Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993. 364: 798-802.
30. Erickson, S. L., Kikly, S. F. de K., Carver, M. K., Pitts, M. S., Gillett, N., Sheehan, K. C., Schreiber, R. D., Goeddel, D. V. and Moore, M. W., Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994. 372: 560-553.
31. Mendel, I., Kerlero, R. N. and Ben, N. A., A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 1995. 25: 1951-1959.